A pilot study of Galectin-3 targeting in chronic kidney fibrosis and kidney function decline

By afschroeder • June 16, 2026

Qin A, Zhou W, Zhang Z, Zhou Q, Wang J, Wang Z, Zhou Z, Sun Q, Su L, Peng Z. A pilot study of Galectin-3 targeting in chronic kidney fibrosis and kidney function decline. BMC Nephrol. 2026 Jun 15. doi: 10.1186/s12882-026-05123-5. Epub ahead of print. PMID: 42298444.

Tags: Cardiology/Epi, Chronic kidney disease, Galectin-3, GB1107, Kidney fibosis, kidney injury, Post Doc, Publications

Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review

Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]

Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer

Moore H, Huppert LA, Moslehi JJ, Yang EH, Hatcher S, Thomas A. Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations:[...]

Association between depressive symptoms and thoracic aortic calcification, and their independent and joint prognostic value for incident atherosclerotic cardiovascular disease in the MESA cohort

Arai D, White Q, Ichikawa K, McClelland RL, Johnson WC, Yabuki M, Hansen S, Budoff MJ. Association between depressive symptoms and thoracic aortic calcification, and[...]